CY1112771T1 - Φαρμακευτικη συνθεση η οποια περιλαμβανει αρτεσουνατη, σουλφαμεθοξυπυραζινη και πυριμεθαμινη για χρηση στην αντιμετωπιση ελονοσιας εντος μιας ημερας - Google Patents
Φαρμακευτικη συνθεση η οποια περιλαμβανει αρτεσουνατη, σουλφαμεθοξυπυραζινη και πυριμεθαμινη για χρηση στην αντιμετωπιση ελονοσιας εντος μιας ημεραςInfo
- Publication number
- CY1112771T1 CY1112771T1 CY20121100431T CY121100431T CY1112771T1 CY 1112771 T1 CY1112771 T1 CY 1112771T1 CY 20121100431 T CY20121100431 T CY 20121100431T CY 121100431 T CY121100431 T CY 121100431T CY 1112771 T1 CY1112771 T1 CY 1112771T1
- Authority
- CY
- Cyprus
- Prior art keywords
- sulfamethoxypyrazine
- pharmaceutical composition
- elonesis
- artesounati
- pyrimethamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η παρούσα εφεύρεση σχετίζεται με μία φαρμακευτική σύνθεση η οποία περιλαμβάνει έναν ανθελονοσιακό παράγοντα επιλεγμένο από την ομάδα η οποία αποτελείται από αρτεμαιθέρα, αρτεαιθέρα, αρτεμισινίνη, διυδροαρτεμισινίνη και αρτεσουνάτη˙ σουλφαμεθοξυπυραζίνη και έναν αναστολέα αναγωγάσης του διυδροφολικού και η οποία περαιτέρω περιλαμβάνει ένα ή περισσότερα φαρμακευτικώς αποδεκτά έκδοχα, φορείς και/ή αραιωτικά κατάλληλα για παροχή αντιμετώπισης της ελονοσίας σε μία περίοδο μίας ημέρας.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2005/009851 WO2007028413A1 (en) | 2005-09-09 | 2005-09-09 | Pharmaceutical composition suitable for the treatment of malaria within one day |
EP05795966A EP1940519B1 (en) | 2005-09-09 | 2005-09-09 | Pharmaceutical composition comprising artesunate, sulfamethoxypyrazine and pyrimethamine for use in the treatment of malaria within one day |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112771T1 true CY1112771T1 (el) | 2016-02-10 |
Family
ID=35207504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100431T CY1112771T1 (el) | 2005-09-09 | 2012-05-08 | Φαρμακευτικη συνθεση η οποια περιλαμβανει αρτεσουνατη, σουλφαμεθοξυπυραζινη και πυριμεθαμινη για χρηση στην αντιμετωπιση ελονοσιας εντος μιας ημερας |
Country Status (8)
Country | Link |
---|---|
EP (2) | EP1940519B1 (el) |
CN (1) | CN101287521A (el) |
AT (1) | ATE548081T1 (el) |
CY (1) | CY1112771T1 (el) |
DK (1) | DK1940519T3 (el) |
ES (1) | ES2380634T3 (el) |
PT (1) | PT1940519E (el) |
WO (1) | WO2007028413A1 (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104784167B (zh) * | 2015-04-02 | 2017-08-15 | 河南黑马动物药业有限公司 | 一种治疗动物附红细胞体病的药物及其制备方法 |
-
2005
- 2005-09-09 WO PCT/EP2005/009851 patent/WO2007028413A1/en active Application Filing
- 2005-09-09 CN CNA200580051544XA patent/CN101287521A/zh active Pending
- 2005-09-09 EP EP05795966A patent/EP1940519B1/en active Active
- 2005-09-09 DK DK05795966.0T patent/DK1940519T3/da active
- 2005-09-09 AT AT05795966T patent/ATE548081T1/de active
- 2005-09-09 PT PT05795966T patent/PT1940519E/pt unknown
- 2005-09-09 EP EP10192206A patent/EP2322244B1/en active Active
- 2005-09-09 ES ES05795966T patent/ES2380634T3/es active Active
-
2012
- 2012-05-08 CY CY20121100431T patent/CY1112771T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT1940519E (pt) | 2012-05-21 |
CN101287521A (zh) | 2008-10-15 |
EP2322244B1 (en) | 2012-11-21 |
EP1940519B1 (en) | 2012-03-07 |
ES2380634T3 (es) | 2012-05-17 |
ATE548081T1 (de) | 2012-03-15 |
EP1940519A1 (en) | 2008-07-09 |
DK1940519T3 (da) | 2012-06-25 |
EP2322244A1 (en) | 2011-05-18 |
WO2007028413A1 (en) | 2007-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1125077T1 (el) | Αγωγη της ανεπαρκειας και ελλειψης βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3 | |
CY1107419T1 (el) | Προφαρμακα αντι-ιικων μεσων απο πιπεραζινη και υποκατεστημενη πιπεριδινη | |
CL2008000489A1 (es) | Metodo para ajustar el perfil de los niveles en sangre o la permeacion de un farmaco desde una composicion; y composicion para la administracion transdermica que comprende a dicho farmaco y un vehiculo farmaceuticamente aceptable. | |
WO2009027644A3 (en) | Compositions for the treatment of neoplastic diseases | |
DE602005010788D1 (de) | Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln | |
ATE477805T1 (de) | 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität | |
UY29245A1 (es) | Combinaciones medicas | |
ATE429921T1 (de) | 9a-carbamoyl- und thiocarbamoylazalide mit antimalariawirkung | |
UY29244A1 (es) | Combinaciones medicas | |
CY1112981T1 (el) | Μεθοδος και συνθεση για την αγωγη της ρινιτιδας | |
CY1110170T1 (el) | Ν-καρβαμοϋλμεθυλ-4(-r)-φαινυλ-2-πυρρολιδινονη, μεθοδος παρασκευης της και φαρμακευτικη χρηση αυτης | |
ATE414092T1 (de) | Phosphoindole als hiv-inhibitoren | |
ECSP056006A (es) | Composiciones farmacéuticas que comprenden una combinación de rapamicina o su derivado y pimecrolimus para el tratamiento de enfermedades inflamatorias e inmunológicamente mediadas | |
UA99742C2 (en) | Dispiro 1,2,4-trioxolane antimalarials | |
CY1109539T1 (el) | Χρηση 5'-μεθυλοθειοαδενοσινης (μτα) στην προληψη και/η θεραπεια αυτοανοσων νοσων και/η απορριψης μοσχευματων | |
DE602004021713D1 (de) | Pharmazeutische formulierungen mit kurzketten-sphingolipiden und ihre verwendung | |
CY1110449T1 (el) | Συνδυασμος δοκεταξελης και φλαβοπιριδinολης | |
WO2009048957A8 (en) | Antimalarial compounds with flexible side-chains | |
EP1503748A4 (en) | DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY | |
CY1112771T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει αρτεσουνατη, σουλφαμεθοξυπυραζινη και πυριμεθαμινη για χρηση στην αντιμετωπιση ελονοσιας εντος μιας ημερας | |
GB2443377A (en) | Anti-malarial composition comprising artesunate and lumefantrine | |
ATE491452T1 (de) | Pharmazeutische zusammensetzung mit antipsychotischer, antidepressiver oder antiepileptischer wirkung mit verringerter nebenwirkung | |
BRPI0600275A (pt) | prótese coronária liberadora de composição medicamentosa para prevenção e tratamento da reestenose e processo de fabricação | |
WO2010032165A3 (en) | Prodrugs of artemisinin | |
UY27628A1 (es) | "2'-halo -3',5'-dialcoxi-fen-1'il-2-imidazolidinas y su uso como un fármaco" |